Advertisement
Journal Home
Search for

Volume 8, Issue 3, Page 3 (March 2010)


View previous. 5 of 22 View next.

Another ARB Gains Approval for Pediatric Hypertension

ELIZABETH MECHCATIE

Olmesartan was approved in February for treating hypertension in young people aged 6–16 years, based on a study of 302 children and adolescents.

PII: S1544-8800(10)70086-5

doi:10.1016/S1544-8800(10)70086-5


View previous. 5 of 22 View next.